Skip to main content
Log in

Immunoscintigraphy with anti-chromogranin A antibodies inpatients with endocrine/neuroendocrine tumors

  • Rapid Communication
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Wiedenmann B., Huttner W.B. Synaptophysin and chromogranins/secretogranins-widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Archiv B. Cell Pathol. 58: 95, 1989.

    Article  CAS  Google Scholar 

  2. Deftos L.J. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr. Rev. 12: 181, 1991.

    Article  CAS  PubMed  Google Scholar 

  3. Settleman J., Nolan J., Angeletti R.H. Chromogranin, an integral membrane protein. J. Biol. Chem. 260: 1641,1985.

    CAS  PubMed  Google Scholar 

  4. Pimplikar S.W., Huttner W.B. Chromogranin B (secretogranin I), a secretory protein of the regulated pathway, is also present in a tightly membrane-associated form in PC12 cells. J. Biol. Chem. 267: 4110, 1992.

    CAS  PubMed  Google Scholar 

  5. Paganelli G., Malcovati M., Fazio F. Monoclonal antibody pretargetting techniques for tumour localization: the avidin-biotin system. Nucl. Med. Commun. 12: 211, 1991.

    Article  CAS  PubMed  Google Scholar 

  6. Paganelli G., Magnani P., Zito F., Villa E., Sudati F., Lopalco L., Rossetti C., Malcovati M., Chiolerio F., Seccamani E., Siccardi A.G., Fazio F. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res. 51: 5960, 1991.

    CAS  PubMed  Google Scholar 

  7. Pelagi M., Bisiani C, Gini A., Bonardi M.A., Rosa P., Marè P., Viale G., Cozzi M.G., Salvatore M., Zanini A., Siccardi A.G., Buffa R. Preparation and characterization of anti-human chromogranin A and chromogranin B (secretogranin I) monoclonal antibodies. Mol. Cell. Probe 3: 87,1989.

    Article  CAS  Google Scholar 

  8. Koch P., Mäcke H.R. Tc-99m labeled biotin conjugate in a tumor ‘pretargeting’ approach with monoclonal antibodies. Angew. Chem. Int. Ed. 31: 1507, 1992.

    Article  Google Scholar 

  9. Schmid K.W., Kröll M., Hittmair A., Maier H., Tötsch M., Gasser R., Finkenstett G., Angeletti R.H., Fischer-Colbrie R. Chromogranin A and B in adenomas of the pituitary. An immunohisto-chemical study of 42 patients. Am. J. Surg.Pathol. 15(11): 1072, 1991.

    Article  CAS  PubMed  Google Scholar 

  10. Jin L, Chandler W.F., Smart J.B., England B.G., Lloyd R.V. Differentiation of human pituitary adenomas determines the pattern of chromogranin/secretogranin messenger ribonucleic acid expression. J. Clin. Endocrinol. Metab. 76: 728, 1993.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Colombo, P., Paganelli, G., Magnani, P. et al. Immunoscintigraphy with anti-chromogranin A antibodies inpatients with endocrine/neuroendocrine tumors. J Endocrinol Invest 16, 841–843 (1993). https://doi.org/10.1007/BF03348939

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348939

Keywords

Navigation